Journal
BIOMEDICINES
Volume 11, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines11051398
Keywords
Alzheimer's disease; molecular mechanism; risk factors; amyloid plaques; tau tangles
Ask authors/readers for more resources
Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by cognitive decline, neurodegeneration, and the formation of amyloid-fi plaques and neurofibrillary tangles. Despite extensive research into the causes and molecular mechanisms of AD, a cure has not yet been found. Extensive disease modeling and understanding of the molecular mechanisms are crucial for the development of effective treatments.
Alzheimer's disease (AD) is the most prominent neurodegenerative disorder in the aging population. It is characterized by cognitive decline, gradual neurodegeneration, and the development of amyloid-fi (Afi)-plaques and neurofibrillary tangles, which constitute hyperphosphorylated tau. The early stages of neurodegeneration in AD include the loss of neurons, followed by synaptic impairment. Since the discovery of AD, substantial factual research has surfaced that outlines the disease's causes, molecular mechanisms, and prospective therapeutics, but a successful cure for the disease has not yet been discovered. This may be attributed to the complicated pathogenesis of AD, the absence of a well-defined molecular mechanism, and the constrained diagnostic resources and treatment options. To address the aforementioned challenges, extensive disease modeling is essential to fully comprehend the underlying mechanisms of AD, making it easier to design and develop effective treatment strategies. Emerging evidence over the past few decades supports the critical role of Afi and tau in AD pathogenesis and the participation of glial cells in different molecular and cellular pathways. This review extensively discusses the current understanding concerning Afi- and tau-associated molecular mechanisms and glial dysfunction in AD. Moreover, the critical risk factors associated with AD including genetics, aging, environmental variables, lifestyle habits, medical conditions, viral/bacterial infections, and psychiatric factors have been summarized. The present study will entice researchers to more thoroughly comprehend and explore the current status of the molecular mechanism of AD, which may assist in AD drug development in the forthcoming era.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available